Catalent Inc (CTLT)
60.98
+1.32
(+2.21%)
USD |
NYSE |
Nov 22, 16:00
60.91
-0.07
(-0.11%)
After-Hours: 20:00
Catalent Cash from Financing (Quarterly): -10.00M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.00M |
| June 30, 2024 | -10.00M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -14.00M |
| September 30, 2023 | 98.00M |
| June 30, 2023 | -51.00M |
| March 31, 2023 | -25.00M |
| December 31, 2022 | 523.00M |
| September 30, 2022 | 74.00M |
| June 30, 2022 | 1.00M |
| March 31, 2022 | -3.00M |
| December 31, 2021 | -49.00M |
| September 30, 2021 | 1.082B |
| June 30, 2021 | -17.00M |
| March 31, 2021 | 166.00M |
| December 31, 2020 | -57.00M |
| September 30, 2020 | 50.00M |
| June 30, 2020 | 331.30M |
| March 31, 2020 | 772.50M |
| December 31, 2019 | -66.00M |
| September 30, 2019 | -35.80M |
| June 30, 2019 | 1.284B |
| March 31, 2019 | -8.70M |
| December 31, 2018 | -55.00M |
| September 30, 2018 | -18.80M |
| Date | Value |
|---|---|
| June 30, 2018 | -5.50M |
| March 31, 2018 | -7.80M |
| December 31, 2017 | 419.40M |
| September 30, 2017 | 263.00M |
| June 30, 2017 | -7.10M |
| March 31, 2017 | -7.30M |
| December 31, 2016 | 109.80M |
| September 30, 2016 | 65.90M |
| June 30, 2016 | -3.70M |
| March 31, 2016 | -6.20M |
| December 31, 2015 | -10.60M |
| September 30, 2015 | -10.30M |
| June 30, 2015 | -12.50M |
| March 31, 2015 | -13.60M |
| December 31, 2014 | 135.70M |
| September 30, 2014 | 86.90M |
| June 30, 2014 | -5.80M |
| March 31, 2014 | -37.00M |
| December 31, 2013 | 13.20M |
| September 30, 2013 | -12.50M |
| June 30, 2013 | 2.10M |
| March 31, 2013 | -8.50M |
| December 31, 2012 | -332.90M |
| September 30, 2012 | 290.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-66.00M
Minimum
Dec 2019
1.082B
Maximum
Sep 2021
139.79M
Average
-1.50M
Median
Cash from Financing (Quarterly) Benchmarks
| Eli Lilly and Co | 211.30M |
| Boston Scientific Corp | 7.00M |
| Pfizer Inc | -4.636B |
| Merck & Co Inc | -2.425B |
| Avid Bioservices Inc | 0.266M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 61.00M |
| Cash from Investing (Quarterly) | -34.00M |
| Free Cash Flow | 99.00M |
| Free Cash Flow Per Share (Quarterly) | 0.022 |
| Free Cash Flow to Equity (Quarterly) | -25.00M |
| Free Cash Flow to Firm (Quarterly) | 70.15M |
| Free Cash Flow Yield | 0.89% |